Du är här

2016-02-05

BB Biotech AG: Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)

BB Biotech AG / Director's Dealings announcement according to §15a WpHG (the
German SecuritiesTrading Act) . Processed and transmitted by NASDAQ OMX
Corporate Solutions.The issuer is solely responsible for the content of this
announcement.
-------------------------------------------------------------------------------------------------------
| Details of the person subject to the disclosure requirement |
| Name: Strein, Klaus |
| Professional role: Person with executive functions: Member of administrative or supervisory |
| body |
| |
| Designation of the financial instrument |
| ISIN: CH0038389992 |
| Designation: Registered share BB Biotech AG |
| |
| Details of the transaction |
| Type of transaction: Buy |
| Date: 04.02.2016 |
| Place (stock exchange): Swiss Stock Exchange |
| Price: 229.463 |
| Currency: CHF |
| Quantity: 2600 |
| Business volume: 596603.80 |
| |
| Details of the company with the publishing obligation: |
| Issuer: |
| BB Biotech AG |
| Schwertstrasse 6 |
| CH-8200 Schaffhausen |
| Switzerland |
-------------------------------------------------------------------------------------------------------
-----------------------
| ISIN: CH0038389992 |
| WKN: 888509 |
-----------------------

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BB Biotech AG via Globenewswire

HUG#1984183

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.